US Stock MarketDetailed Quotes

COYA Coya Therapeutics

Watchlist
  • 5.720
  • +0.030+0.53%
Trading May 15 12:25 ET
95.67MMarket Cap-5.35P/E (TTM)

Coya Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
17.51%38.34M
17.51%38.34M
185.29%31.06M
179.15%36.58M
120.52%35.99M
449.86%32.63M
449.86%32.63M
25.84%10.89M
--13.1M
--16.32M
-Cash and cash equivalents
17.51%38.34M
17.51%38.34M
185.29%31.06M
179.15%36.58M
120.52%35.99M
449.86%32.63M
449.86%32.63M
25.84%10.89M
--13.1M
--16.32M
Receivables
-90.26%730.58K
-90.26%730.58K
--0
--0
--0
--7.5M
--7.5M
----
----
----
-Taxes receivable
--730.58K
--730.58K
----
----
----
--0
--0
----
----
----
-Other receivables
----
----
----
----
----
--7.5M
--7.5M
----
----
----
Prepaid assets
389.74%5.24M
389.74%5.24M
--4.45M
--3.31M
--1.34M
-14.52%1.07M
-14.52%1.07M
----
----
----
Other current assets
----
----
----
----
----
----
----
1,594.76%936.35K
--1.29M
--1.01M
Total current assets
7.55%44.31M
7.55%44.31M
200.33%35.51M
177.19%39.89M
115.40%37.33M
473.37%41.2M
473.37%41.2M
35.80%11.82M
--14.39M
--17.33M
Non current assets
Net PPE
-41.49%38.59K
-41.49%38.59K
-37.59%45.43K
-34.36%52.27K
-31.64%59.11K
-29.32%65.95K
-29.32%65.95K
-27.32%72.79K
--79.63K
--86.47K
-Gross PPE
0.00%136.8K
0.00%136.8K
----
----
----
0.00%136.8K
0.00%136.8K
----
----
----
-Accumulated depreciation
-38.62%-98.22K
-38.62%-98.22K
----
----
----
-62.91%-70.86K
-62.91%-70.86K
----
----
----
Non current deferred assets
----
----
----
----
----
----
----
--0
--0
--0
Total non current assets
-41.49%38.59K
-41.49%38.59K
-37.59%45.43K
-34.36%52.27K
-31.64%59.11K
-94.55%65.95K
-94.55%65.95K
-79.69%72.79K
--79.63K
--86.47K
Total assets
7.48%44.35M
7.48%44.35M
198.87%35.55M
176.02%39.94M
114.67%37.39M
391.48%41.26M
391.48%41.26M
31.23%11.9M
--14.47M
--17.42M
Liabilities
Current liabilities
Payables
-15.50%1.59M
-15.50%1.59M
-46.89%336.72K
692.61%1.88M
326.73%2.31M
3.54%1.88M
3.54%1.88M
-51.74%633.95K
--237.58K
--541.75K
-accounts payable
37.42%1.59M
37.42%1.59M
-46.89%336.72K
692.61%1.88M
193.11%1.59M
-36.34%1.16M
-36.34%1.16M
-51.74%633.95K
--237.58K
--541.75K
-Total tax payable
--0
--0
--0
--0
--723.85K
--723.85K
--723.85K
----
----
----
Current accrued expenses
-38.29%1.39M
-38.29%1.39M
20.17%1.41M
1.99%1M
81.83%1.32M
12.00%2.25M
12.00%2.25M
-7.16%1.17M
--983.63K
--724.69K
Current deferred liabilities
-8.11%848.29K
-8.11%848.29K
--573.09K
--939.04K
--689.67K
--923.11K
--923.11K
----
----
----
Current liabilities
-24.30%3.82M
-24.30%3.82M
28.36%2.32M
213.24%3.83M
241.05%4.32M
32.13%5.05M
32.13%5.05M
-29.89%1.81M
--1.22M
--1.27M
Non current liabilities
Non current deferred liabilities
64.52%945.45K
64.52%945.45K
--1.22M
--856.65K
--681.29K
--574.69K
--574.69K
----
----
----
Total non current liabilities
64.52%945.45K
64.52%945.45K
--1.22M
--856.65K
--681.29K
-95.57%574.69K
-95.57%574.69K
--0
--0
--0
Total liabilities
-15.23%4.77M
-15.23%4.77M
96.04%3.54M
283.39%4.68M
294.84%5M
-66.49%5.63M
-66.49%5.63M
-87.47%1.81M
--1.22M
--1.27M
Shareholders'equity
Share capital
15.96%1.67K
15.96%1.67K
52.91%1.52K
52.91%1.52K
46.79%1.46K
-99.98%1.44K
-99.98%1.44K
-99.99%996
--996
--996
-common stock
15.96%1.67K
15.96%1.67K
52.91%1.52K
52.91%1.52K
46.79%1.46K
456.37%1.44K
456.37%1.44K
284.56%996
--996
--996
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-57.55%-40.74M
-57.55%-40.74M
-39.45%-37.82M
-42.61%-33.8M
-50.00%-30.91M
-44.70%-25.86M
-44.70%-25.86M
-83.74%-27.12M
---23.7M
---20.61M
Paid-in capital
30.59%80.31M
30.59%80.31M
87.66%69.83M
86.90%69.06M
72.62%63.45M
8,929.70%61.5M
8,929.70%61.5M
6,003.26%37.21M
--36.95M
--36.76M
Other equity interest
----
----
----
----
---149.25K
---11.25K
---11.25K
----
----
----
Total stockholders'equity
11.06%39.58M
11.06%39.58M
217.28%32.01M
166.13%35.26M
100.55%32.39M
524.56%35.64M
524.56%35.64M
288.32%10.09M
--13.25M
--16.15M
Total equity
11.06%39.58M
11.06%39.58M
217.28%32.01M
166.13%35.26M
100.55%32.39M
524.56%35.64M
524.56%35.64M
288.32%10.09M
--13.25M
--16.15M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments 17.51%38.34M17.51%38.34M185.29%31.06M179.15%36.58M120.52%35.99M449.86%32.63M449.86%32.63M25.84%10.89M--13.1M--16.32M
-Cash and cash equivalents 17.51%38.34M17.51%38.34M185.29%31.06M179.15%36.58M120.52%35.99M449.86%32.63M449.86%32.63M25.84%10.89M--13.1M--16.32M
Receivables -90.26%730.58K-90.26%730.58K--0--0--0--7.5M--7.5M------------
-Taxes receivable --730.58K--730.58K--------------0--0------------
-Other receivables ----------------------7.5M--7.5M------------
Prepaid assets 389.74%5.24M389.74%5.24M--4.45M--3.31M--1.34M-14.52%1.07M-14.52%1.07M------------
Other current assets ----------------------------1,594.76%936.35K--1.29M--1.01M
Total current assets 7.55%44.31M7.55%44.31M200.33%35.51M177.19%39.89M115.40%37.33M473.37%41.2M473.37%41.2M35.80%11.82M--14.39M--17.33M
Non current assets
Net PPE -41.49%38.59K-41.49%38.59K-37.59%45.43K-34.36%52.27K-31.64%59.11K-29.32%65.95K-29.32%65.95K-27.32%72.79K--79.63K--86.47K
-Gross PPE 0.00%136.8K0.00%136.8K------------0.00%136.8K0.00%136.8K------------
-Accumulated depreciation -38.62%-98.22K-38.62%-98.22K-------------62.91%-70.86K-62.91%-70.86K------------
Non current deferred assets ------------------------------0--0--0
Total non current assets -41.49%38.59K-41.49%38.59K-37.59%45.43K-34.36%52.27K-31.64%59.11K-94.55%65.95K-94.55%65.95K-79.69%72.79K--79.63K--86.47K
Total assets 7.48%44.35M7.48%44.35M198.87%35.55M176.02%39.94M114.67%37.39M391.48%41.26M391.48%41.26M31.23%11.9M--14.47M--17.42M
Liabilities
Current liabilities
Payables -15.50%1.59M-15.50%1.59M-46.89%336.72K692.61%1.88M326.73%2.31M3.54%1.88M3.54%1.88M-51.74%633.95K--237.58K--541.75K
-accounts payable 37.42%1.59M37.42%1.59M-46.89%336.72K692.61%1.88M193.11%1.59M-36.34%1.16M-36.34%1.16M-51.74%633.95K--237.58K--541.75K
-Total tax payable --0--0--0--0--723.85K--723.85K--723.85K------------
Current accrued expenses -38.29%1.39M-38.29%1.39M20.17%1.41M1.99%1M81.83%1.32M12.00%2.25M12.00%2.25M-7.16%1.17M--983.63K--724.69K
Current deferred liabilities -8.11%848.29K-8.11%848.29K--573.09K--939.04K--689.67K--923.11K--923.11K------------
Current liabilities -24.30%3.82M-24.30%3.82M28.36%2.32M213.24%3.83M241.05%4.32M32.13%5.05M32.13%5.05M-29.89%1.81M--1.22M--1.27M
Non current liabilities
Non current deferred liabilities 64.52%945.45K64.52%945.45K--1.22M--856.65K--681.29K--574.69K--574.69K------------
Total non current liabilities 64.52%945.45K64.52%945.45K--1.22M--856.65K--681.29K-95.57%574.69K-95.57%574.69K--0--0--0
Total liabilities -15.23%4.77M-15.23%4.77M96.04%3.54M283.39%4.68M294.84%5M-66.49%5.63M-66.49%5.63M-87.47%1.81M--1.22M--1.27M
Shareholders'equity
Share capital 15.96%1.67K15.96%1.67K52.91%1.52K52.91%1.52K46.79%1.46K-99.98%1.44K-99.98%1.44K-99.99%996--996--996
-common stock 15.96%1.67K15.96%1.67K52.91%1.52K52.91%1.52K46.79%1.46K456.37%1.44K456.37%1.44K284.56%996--996--996
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -57.55%-40.74M-57.55%-40.74M-39.45%-37.82M-42.61%-33.8M-50.00%-30.91M-44.70%-25.86M-44.70%-25.86M-83.74%-27.12M---23.7M---20.61M
Paid-in capital 30.59%80.31M30.59%80.31M87.66%69.83M86.90%69.06M72.62%63.45M8,929.70%61.5M8,929.70%61.5M6,003.26%37.21M--36.95M--36.76M
Other equity interest -------------------149.25K---11.25K---11.25K------------
Total stockholders'equity 11.06%39.58M11.06%39.58M217.28%32.01M166.13%35.26M100.55%32.39M524.56%35.64M524.56%35.64M288.32%10.09M--13.25M--16.15M
Total equity 11.06%39.58M11.06%39.58M217.28%32.01M166.13%35.26M100.55%32.39M524.56%35.64M524.56%35.64M288.32%10.09M--13.25M--16.15M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Lennar Corp
LEN
109.690
Meritage Homes
MTH
67.955
Adobe
ADBE
403.528
4
Vale SA
VALE
9.870
5
Microsoft
MSFT
454.900
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025

Monetary Policy: Navigating the Fed's Rate Cut Cycle

Changing Fed policy is altering the market math for investors.